Literature DB >> 7177275

Effect of hemodialysis on the pharmacokinetics of theophylline in chronic renal failure.

W A Kradjan, T R Martin, C J Delaney, A D Blair, R E Cutler.   

Abstract

We studied theophylline elimination in 8 patients with chronic renal failure to determine the effect of hemodialysis on the pharmacokinetics of theophylline. Each subject was studied twice, once on a nondialysis day and again during dialysis. Total body theophylline clearance on the nondialysis day was similar to that reported for patients with normal renal function (57.4 +/- 27.2 ml/kg/h). Hemodialysis accelerated theophylline elimination and shortened serum theophylline half-life in all patients (nondialysis t 1/2 = 7.3 h +/- 2.3 vs. dialysis t 1/2 = 2.7 +/- 0.9 h, p less than 0.01). Dialysis clearance averaged 59.7 +/- 16.4 ml/kg/h with a fraction of drug removed of 0.4 liters in 4 h. Guidelines for theophylline management during hemodialysis are suggested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7177275     DOI: 10.1159/000182729

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

Review 1.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

2.  The ex vivo plasma protein binding of theophylline in renal disease.

Authors:  D Leopold; D Webb; D C Buss; R A Fifield; A P Smith; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.